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Genetically Engineered V79 Chinese
Hamster Cells Metabolically Activate the
Cytostatic Drugs Cyclophosphamide and
Ifosfamide
by J. Doehmer,* A. Seidel,* F. Oesch,* and H. R. Glatt*
V79 cells, genetically engineered to express active cytochromes P450IIB1 and P450IA1, were used to
study the cytotoxicity and mutagenicity of cyclophosphamide and ifosfamide. Cyclophosphamide, tested
up to a concentration of 2 mM, was not cytotoxic in V79 nor in the P450IA1-expressing V79-derived cell
line XEM2. Pronounced cytotoxicity was, however, observed in the P450IIB1-expressing V79-derived cell
line SDL. Induction of gene mutations (acquisition of6-thioguanine resistance) was observed in SD1 cells
as well, but the effects were weak. Ifosfamide was inactive in V79 cells, but was cytotoxic in SDl cells.
Ifosfamide mustard, an active metabolite of ifosfamide, was equally cytotoxic and showed similar mu-
tagenic effects in SDl and parental V79 cells. The results indicate that cyclophosphamide and ifosfamide
are metabolically activated by cytochrome P4501IB1. In contrast, cytochrome P450IA1 was not capable
ofactivating cyclophosphamide. Thus, V79-derived cell lines defined for their expression of a specific form
of cytochrome P-450 can be used as diagnostic tools to identify the cytochrome P-450 that is responsible
for the metabolic activation of drugs.
Introduction
V79 Chinese hamster cells have been used for mu-
tagenicity testing for more than 10 years because they
are easy to cultivate, grow rapidly, and have a stable
karyotype with just one X-chromosome harboring the
HPRTlocus, whichis convenientformutagenicity stud-
ies. Chemicals are tested for their mutagenic potential
by counting HPRT- mutants surviving in medium con-
taining6-thioguanine. However, the situation gets com-
plicated when the chemicals investigated are mutagenic
only after metabolic activation because V79 do not ex-
press the cytochromes P-450. The cytochromes P-450
play a crucial role in the activation ofmost xenobiotics.
The problem was circumvented by combining V79 cells
with freshly prepared liver homogenate or liver cells,
but this also created new problems. Externally gener-
ated metabolites might not be able to enter the V79
cells. They may react with macromolecules contained
intheliverhomogenate. Forshort-lived metabolites the
diffusion pathways may be too long. In other cases the
plasma membrane may act as a barrier. In any case,
such metabolites would remain undetected and false
negative results would be observed.
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Forthis reasonwe have started aprogramemploying
genetechnologytoprovide V79cellswithnewmetabolic
capabilities related to xenobiotic metabolism. A V79-
derived cell line expressing rat P450IIB1 (SD1) (1) and
a V79-derived cell line expressingrat P450IA1 (XEM2)
(2) have recently been established and characterized.
Here, we demonstrate the application ofthese cell lines
as diagnostic tools in drug metabolism studies.
Materials and Methods
Chemicals and Cell Culture
Cyclophosphamide, ifosfamide, and ifosfamide mus-
tard were a gift of ASTA-Werke (Bielefeld, FRG).
V79 Chinese hamster cells and V79-derived cell lines
SD1 and XEM2 were maintained in Dulbecco-Vogt's
modified Eagle's medium (DMEM) supplemented with
5 to 10% fetal calf serum, penicillin (100 U/mL), and
streptomycin (100 ,ug/mL). For the SD1 and XEM2
stock cultures, the medium also contained 400 ,ug/mL
G418.
Cytotoxicity andmutagenicityexperiments were car-
ried out as described previously (3). Briefly, 1.5 x 106
cells and 30 mL medium were seeded into a 15-cm Petri
dish. After 18 hr, the test compound, dissolved in me-
dium, was added. The exposure was terminated by a
change of the medium 24 hr later. After an expressionDOEHMER ETAL.
period of 6 days, with one subculture, the cells were
counted and replated at a density of106 per 15-cm Petri
dish in medium containing 6-thioguanine (six replicate
plates), or at a density of 100 cells per 6-cm Petri dish
in medium without 6-thioguanine for the determination
of cloning efficiency. The cultures were fixed and
stained, and the colonies counted after about 7 days
(cloning efficiency plates) or 10 days (selection plates).
From these values, mutation frequencies were calcu-
lated.
Results
V79 cells survived in medium containing cyclophos-
phamide even at a concentration of2 mM, whereas SD1
cells died in the presence ofcyclophosphamide in a con-
centration-dependent manner, 98% of the cells being
killed at an exposure concentration of 2 mM (Fig. 1).
In medium containing ifosfamide, V79 cells survived,
whereas SD1 cells died (Fig. 2). In contrast, ifosfamide
mustard, an active metabolite of ifosfamide, showed
similar cytotoxic activities in V79 and SD1 cells (Fig.
3).
The compounds were also investigated for the induc-
tion ofgene mutations (Table 1). Cyclophosphamide and
ifosfamide showed no effect in V79 cells, whereas cy-
clophosphamide weakly elevated the mutation fre-
quency, and ifosfamide did not clearly elevate the mu-
tation frequency in SD1 cells. These effects, which are
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FIGURE 1. SurvivingV79(0), XEM2 (*), and SD1 (+ ) cellsexposed
to cyclophosphamide at various concentrations. Cells were ex-
posed to cyclophosphamide for 24 hr and cultured for 5 additional
days. In the middle of this expression period, the cultures were
diluted to a density of 3 x 106 cells per plate. The figure shows
the cell numbers at the end of the expression period, corrected
for the dilution factor. Mutation frequencies, determined in the
same experiment, are shown in Table 1.
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FIGURE 2. Surviving V79 (0) and SDl (+) cells exposed to ifos-
famide at various concentrations. The experimental conditions are
described in the legend to Figure 1.
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FIGURE 3. Surviving V79 (0) and SD1 (+) cells exposed to ifos-
famide mustard at various concentrations. The experimental con-
ditions are described in the legend to Figure 1.
just above the detection limit, have not been verified in
repeat experiments, as cytotoxicity obviously was the
more useful end point for studying the metabolic acti-
vation ofthese cytostatics. Ifosfamide mustard showed
clear but weak mutagenicity in both SD1 and V79 cells.
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Table 1. Mutagenicity of cyclophosphamide, ifosfamide, and
ifosfamide mustard in V79 and SD1 cells.a
Mutation frequency x 106
Test compound Concentration, ,uM V79 SD1
Cyclophosphamide 0 0, 5 1, 3
20 5 3
50 4 6
100 4 5
200 7 12
500 3 12
1000 5 30
Ifosfamide 0 8, 11 3, 8
50 6 3
100 13 7
200 12 4
500 12 12
1000 15 18
2000 16 13
Ifosfamide mustard 0.0 5, 11 1, 2
6.2 15 8
12.3 66 21
24.6 43 40
aAcquisition of resistance to 6-thioguanine served as the marker
for mutagenicity. Each value represents one treated culture and is
based on six selection plates. The cytotoxicity data for the same ex-
periment is shown in Figures 1-3.
Discussion
There are manyindications inthe literature that met-
abolic activation ofcyclophosphamide by cytochrome P-
450is necessary forthe generation ofthe mustard form,
which is the penultimate cytotoxic compound. The ob-
servation that pretreatment ofanimals with phenobar-
bital increases the liver-enzyme-mediated bacterial mu-
tagenicity of cyclophosphamide indicate that
phenobarbital-inducible enzymes are involved in its ac-
tivation (4). Usingthe V79-derived cell lines defined for
the expression of one specific cytochrome P-450 form,
we were able to show that cyclophosphamide is indeed
activated by P450IIB1 expressed in the cell line SD1,
themajorphenobarbital-inducible cytochromeP-450. In
contrast, no activation was observed with P450IA1 ex-
pressed in the cell line XEM2 (Fig. 1).
Ifosfamide is a structural isomer of cyclophospha-
mide. The differential cytotoxicity observed in this
study demonstrates that this compound also requires
metabolic activation and that P450IIB1 is capable of
carrying it out. The finding that ifosfamide mustard
showed very similar cytotoxic and mutagenic effects in
V79 and SD1 cells confirms that the differences ob-
served with the precursor ifosfamide are at the level
metabolic activation.
Cyclophosphamide and ifosfamide showed strong cy-
totoxicity, but onlymarginalmutagenicity, in SD1 cells.
The same holds for ifosfamide mustard in SD1 as well
as in V79 cells. These observations suggest that the
induction of gene mutations is not a major mechanism
for the cytotoxicity of these compounds, at least if the
HPRT gene is considered representative.
Thus, it has been demonstrated that genetically en-
gineered V79 cells expressing xenobiotic-metabolizing
enzymes are a valuable tool for the evaluation of the
metabolism and pharmacological action of drugs.
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